Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-009314
Filing Date
2024-03-06
Accepted
2024-03-06 10:09:49
Documents
14
Period of Report
2024-03-06

Document Format Files

Seq Description Document Type Size
1 6-K a240306_6kxmorxvotingright.htm 6-K 11068
2 EX-99.1 exhibit_991.htm EX-99.1 6979
3 EX-99.2 exhibit_992.htm EX-99.2 6248
4 GRAPHIC exhibit_991001.jpg GRAPHIC 116950
5 GRAPHIC exhibit_991002.jpg GRAPHIC 129837
6 GRAPHIC exhibit_991003.jpg GRAPHIC 129907
7 GRAPHIC exhibit_991004.jpg GRAPHIC 89636
8 GRAPHIC exhibit_991005.jpg GRAPHIC 107550
9 GRAPHIC exhibit_991006.jpg GRAPHIC 59586
10 GRAPHIC exhibit_992001.jpg GRAPHIC 116829
11 GRAPHIC exhibit_992002.jpg GRAPHIC 124514
12 GRAPHIC exhibit_992003.jpg GRAPHIC 130894
13 GRAPHIC exhibit_992004.jpg GRAPHIC 87472
14 GRAPHIC exhibit_992005.jpg GRAPHIC 81508
  Complete submission text file 0001628280-24-009314.txt   1644094
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24724625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)